AAAAAA
Results:
1-15
|
Results: 15
Authors:
Djurovic, S
Os, I
Hofstad, AE
Abdelnoor, M
Westheim, A
Berg, K
Citation: S. Djurovic et al., Increased plasma concentrations of TGF-beta(1) after hormone replacement therapy (vol 247, pg 279, 2000), J INTERN M, 249(3), 2001, pp. 271-271
Authors:
Boulatov, VA
Stenehjem, A
Os, I
Citation: Va. Boulatov et al., Association between Albumin : Creatinine ratio and 24-hour ambulatory blood pressure in essential hypertension, AM J HYPERT, 14(4), 2001, pp. 338-344
Authors:
Bulatov, VA
Stenehjem, A
Os, I
Citation: Va. Bulatov et al., Left ventricular mass assessed by electrocardiography and albumin excretion rate as a continuum in untreated essential hypertension, J HYPERTENS, 19(8), 2001, pp. 1473-1478
Authors:
Sevre, K
Lefrandt, JD
Nordby, G
Os, I
Mulder, M
Gans, ROB
Rostrup, M
Smit, AJ
Citation: K. Sevre et al., Autonomic function in hypertensive and normotensive subjects - The importance of gender, HYPERTENSIO, 37(6), 2001, pp. 1351-1356
Authors:
Os, I
Strom, EH
Stenehjem, A
Gudmundsdottir, H
Langberg, H
Draganov, B
Godoy, J
Dunlop, O
von der Lippe, B
Citation: I. Os et al., Varicella infection in a renal transplant recipient associated with abdominal pain, hepatitis, and glomerulonephritis, SC J UROL N, 35(4), 2001, pp. 330-333
Authors:
Os, I
Hofstad, AE
Brekke, M
Abdelnoor, M
Nesheim, BI
Jacobsen, AF
Birkeland, K
Larsen, A
Midtbo, K
Westheim, A
Citation: I. Os et al., The EWA (Estrogen in Women with Atherosclerosis) Study: a randomized studyof the use of hormone replacement therapy in women with angiographically verified coronary artery disease. Characteristics of the study population. Effects on lipids and lipoproteins, J INTERN M, 247(4), 2000, pp. 433-441
Authors:
Djurovic, S
Os, I
Hofstad, AE
Abdelonoor, M
Westheim, A
Berg, K
Citation: S. Djurovic et al., Increased plasma concentrations of TGF-beta(1) after hormone replacement therapy, J INTERN M, 247(2), 2000, pp. 279-285
Authors:
Kjeldsen, SE
Os, I
Farsang, C
Mallion, JM
Hansson, L
Sleight, P
Citation: Se. Kjeldsen et al., Treatment of hypertension in patients with type-2 diabetes mellitus, BLOOD PRESS, 9(6), 2000, pp. 363-364
Authors:
Seljeflot, I
Arnesen, H
Hofstad, AE
Os, I
Citation: I. Seljeflot et al., Reduced expression of endothelial cell markers after long-term transdermalhormone replacement therapy in women with coronary artery disease, THROMB HAEM, 83(6), 2000, pp. 944-948
Authors:
Kjeldsen, SE
Os, I
Farsang, C
Mallion, JM
Hansson, L
Sleight, P
Citation: Se. Kjeldsen et al., Treatment of hypertension in patients with type-2 diabetes mellitus, J HYPERTENS, 18(9), 2000, pp. 1345-1346
Authors:
Kjeldsen, SE
Westheim, AS
Os, I
Citation: Se. Kjeldsen et al., INSIGHT and NORDIL - Reply, LANCET, 356(9245), 2000, pp. 1929-1930
Authors:
Hoibraaten, E
Os, I
Seljeflot, I
Andersen, TO
Hofstad, AE
Sandset, PM
Citation: E. Hoibraaten et al., The effects of hormone replacement therapy on hemostatic variables in women with angiographically verified coronary artery disease: Results from the estrogen in women with atherosclerosis study, THROMB RES, 98(1), 2000, pp. 19-27
Authors:
Os, I
Stokke, HP
Citation: I. Os et Hp. Stokke, Doxazosin GITS compared with doxazosin standard and placebo in patients with mild hypertension, BLOOD PRESS, 8(3), 1999, pp. 184-191
Authors:
Os, I
Stokke, HP
Citation: I. Os et Hp. Stokke, Effects of doxazosin in the gastrointestinal therapeutic system formulation versus doxazosin standard and placebo in mild-to-moderate hypertension, J CARDIO PH, 33(5), 1999, pp. 791-797
Authors:
Hofstad, AE
Os, I
Abdelnoor, M
Platou, ES
Westheim, A
Citation: Ae. Hofstad et al., Evidence of excess hereditary predisposition in women with angiographically documented coronary artery disease, CARDIOLOGY, 90(4), 1998, pp. 249-252
Risultati:
1-15
|